[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1880 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1880

   To require, on the occasion of the 30th anniversary of the first 
reported cases of AIDS, reporting on the implementation of the National 
 HIV/AIDS Strategy and on the status of international progress towards 
    achieving universal access to HIV/AIDS treatment, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 12, 2011

   Ms. Lee of California (for herself, Mr. Grijalva, Mr. Moran, Mr. 
     Conyers, Mr. Meeks, Ms. Norton, Mr. Towns, Mr. Courtney, Ms. 
  Schakowsky, Mr. Frank of Massachusetts, Ms. Wilson of Florida, Mr. 
   Cohen, Ms. Richardson, Mr. Nadler, Mrs. Maloney, Mr. Serrano, Mr. 
Rangel, Mr. Stark, Ms. Bordallo, Ms. Bass of California, Mr. Ackerman, 
   Ms. Baldwin, Mr. Becerra, Ms. Berkley, Mr. Bishop of Georgia, Mr. 
  Braley of Iowa, Ms. Brown of Florida, Mr. Cicilline, Mr. Clarke of 
 Michigan, Ms. Clarke of New York, Mr. Clay, Mr. Cleaver, Mr. Clyburn, 
    Ms. DeGette, Mr. Crowley, Mr. Davis of Illinois, Mrs. Davis of 
  California, Ms. DeLauro, Mr. Doggett, Ms. Edwards, Mr. Ellison, Mr. 
Farr, Mr. Fattah, Mr. Garamendi, Mr. Gene Green of Texas, Ms. Hanabusa, 
   Mr. Hastings of Florida, Mr. Higgins, Mr. Holden, Mr. Honda, Ms. 
  Jackson Lee of Texas, Mr. Larson of Connecticut, Ms. Eddie Bernice 
Johnson of Texas, Mr. Johnson of Georgia, Mr. Langevin, Mr. Levin, Mr. 
McNerney, Ms. Moore, Mrs. Napolitano, Mr. Pastor of Arizona, Mr. Payne, 
 Mr. Price of North Carolina, Mr. Reyes, Mr. Richmond, Mr. Rahall, Ms. 
Roybal-Allard, Mr. David Scott of Georgia, Ms. Sewell, Ms. Speier, Mr. 
 Thompson of Mississippi, Mr. Tonko, Ms. Tsongas, Mr. Van Hollen, Ms. 
Velazquez, Ms. Wasserman Schultz, Ms. Waters, Mr. Watt, Mr. Waxman, Mr. 
 Weiner, Ms. Woolsey, Mr. McDermott, Ms. Pingree of Maine, Mr. Doyle, 
   Mr. Tierney, Mr. Schiff, Mr. Olver, Mr. Rush, and Mr. Jackson of 
  Illinois) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
  Foreign Affairs, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
   To require, on the occasion of the 30th anniversary of the first 
reported cases of AIDS, reporting on the implementation of the National 
 HIV/AIDS Strategy and on the status of international progress towards 
    achieving universal access to HIV/AIDS treatment, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Status Report on the 30th 
Anniversary of HIV/AIDS Act''.

SEC. 2. FINDINGS.

    The Congress makes the following findings:
            (1) On June 5, 1981, in the Morbidity and Mortality Weekly 
        Report (MMWR), the Centers for Disease Control and Prevention 
        (CDC) reported the identification of 5 cases of pneumocystis 
        carinii pneumonia (PCP), a rare type of pneumonia typically 
        caused by a suppressed immune system.
            (2) In 1982, public health officials began to use the term 
        ``acquired immunodeficiency syndrome'' or AIDS, to describe the 
        occurrence of opportunistic infections among previously healthy 
        people that were subsequently associated with the initial 5 
        cases of PCP identified in the MMWR. In 1983, scientists 
        isolated and identified the virus that causes AIDS, which 
        became known as human immunodeficiency virus (HIV).
            (3) HIV can be transmitted between persons through 
        unprotected sexual contact, including vaginal, anal, or oral 
        sex, through contaminated injection needles or blood 
        transfusions, and from a mother to child during pregnancy or 
        through breast milk. HIV cannot be transmitted through saliva, 
        tears, or sweat, casual contact, mosquitoes or other insects, 
        or through the air or water.
            (4) The Joint United Nations Programme on HIV/AIDS (UNAIDS) 
        estimates that since the identification of AIDS in 1981, more 
        than 60,000,000 people have been infected with HIV, and nearly 
        30,000,000 people have died of AIDS worldwide.
            (5) In 2009, 33,300,000 people were living with HIV around 
        the world, 1,800,000 people died of AIDS-related illnesses, and 
        another 2,600,000 people were newly infected. Of these numbers, 
        children under the age of 15 accounted for 260,000 AIDS deaths, 
        370,000 new HIV infections, and a total of 2,500,000 of all 
        people living with HIV.
            (6) Developing countries continue to bear the brunt of the 
        AIDS pandemic with sub-Saharan Africa accounting for 68 percent 
        of all adults and children living with HIV, 60 percent of whom 
        are women and girls.
            (7) In 2008, the Tom Lantos and Henry J. Hyde United States 
        Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria 
        Reauthorization Act was enacted into law, reauthorizing the 
        President's Emergency Plan for AIDS Relief (PEPFAR) and 
        continued United States participation and contributions to the 
        Global Fund to Fight AIDS, Tuberculosis and Malaria.
            (8) Nearly 4.7 million people around the world currently 
        receive support for antiretroviral treatment as a result of 
        PEPFAR bilateral programs, the Global Fund, or both.
            (9) According to a recent report by the United Nations 
        Secretary-General, more than 6 million people were estimated to 
        be receiving antiretroviral therapy in low- and middle-income 
        countries as of December 2010, while about 10 million people 
        who could benefit from treatment were not receiving it in 2009.
            (10) In November 2010, UNAIDS and the World Health 
        Organization launched the concept of ``Treatment 2.0'', a 
        radically simplified HIV treatment platform to achieve the goal 
        of preventing 10 million deaths and reducing new HIV infections 
        by up to 1 million annually by optimizing drug regimens, 
        simplifying laboratory platforms for diagnosis and monitoring, 
        reducing costs, adapting delivery systems, and mobilizing 
        communities.
            (11) The CDC estimates that in the United States, more than 
        1,100,000 people are living with HIV, and approximately 21 
        percent do not know they are infected.
            (12) Each year, 56,300 people become newly infected with 
        HIV in the United States, and on average, an individual is 
        infected with HIV every 9\1/2\ minutes.
            (13) A total of 617,025 people have died of AIDS in the 
        United States from the beginning of the HIV/AIDS epidemic 
        through 2008.
            (14) At the end of 2008, African-Americans represented 48 
        percent of all people living with HIV in the United States, 
        Whites represented 33 percent, Hispanics represented 17 
        percent, Asian-Americans and Pacific Islanders represented 1 
        percent, and American Indians and Alaska Natives represented 
        less than 1 percent.
            (15) The leading transmission category of HIV infection in 
        the United States is male-to-male sexual contact, followed by 
        heterosexual contact and injection drug use.
            (16) Men who have sex with men (MSM) of all races remain 
        the population most severely affected by the disease, 
        accounting for 54 percent of all new HIV infections in 2008, 
        with young MSM of color representing an increasing share of new 
        HIV infections over the past decade. African-American MSM 
        account for 35 percent of all new infections among all MSM and 
        63 percent of all new infections among African-American men, 
        while Hispanic MSM account for 19 percent of all new infections 
        among all MSM and 72 percent of new infections among Hispanic 
        men.
            (17) Among women, the rate of new HIV infection for 
        African-American women is nearly 15 times higher than White 
        women, while the rate among Hispanic women is nearly 4 times 
        higher.
            (18) In 1998, Congress and the Clinton Administration 
        created the National Minority AIDS Initiative to provide 
        technical assistance, build capacity, and strengthen outreach 
        efforts among local institutions and community, based 
        organizations that serve racial and ethnic minorities living 
        with or vulnerable to HIV/AIDS.
            (19) In 2009, the Ryan White HIV/AIDS Treatment Extension 
        Act of 2009 was enacted into law, reauthorizing Federal HIV/
        AIDS care and treatment programs for 4 years and making funding 
        available to United States metropolitan areas, States, and 
        service providers to assist affected families and persons 
        living with HIV/AIDS with health care and support services.
            (20) As of April 7, 2011, approximately 7,900 people across 
        11 States were waiting to receive AIDS treatment through the 
        AIDS Drug Assistance Program authorized by the Ryan White CARE 
        Act.
            (21) On July 13, 2010, the President released a ``National 
        HIV/AIDS Strategy for the United States'' along with an 
        accompanying ``Federal Implementation Plan'' to achieve the 
        goals of reducing new HIV infections, increasing access to care 
        and improving health outcomes for people living with HIV, 
        reducing HIV-related disparities and health inequities, and 
        achieving a more coordinated national response to the HIV 
        epidemic.
            (22) In recognition of the 30th anniversary of the first 
        reported cases of AIDS, the United Nations General Assembly 
        will hold a High Level Meeting on AIDS from June 8-10, 2011, to 
        consider a new Declaration of Commitment on HIV/AIDS from 
        United Nations member states.
            (23) The 19th International AIDS Conference will be held in 
        Washington, DC, from July 22-27, 2012, returning to the United 
        States after a nearly two decade long international boycott 
        that was lifted following the statutory repeal of a ban on 
        travel and immigration of people living with HIV/AIDS.

SEC. 3. REPORT ON THE IMPLEMENTATION OF THE NATIONAL HIV/AIDS STRATEGY.

    (a) Report Required.--Not later that 6 months after the date of the 
enactment of this Act, the President, in consultation with the heads of 
all relevant agencies including the Department of Education, the 
Department of Health and Human Services, the Department of Housing and 
Urban Development, the Department of Justice, the Department of Labor, 
the Department of Veterans Affairs, and the Social Security 
Administration, shall transmit to the Congress and make publicly 
available a report on the status of the implementation of the National 
HIV/AIDS Strategy.
    (b) Contents.--The report required by subsection (a) shall include 
a description, analysis, and evaluation of--
            (1) key steps taken by the Federal Government towards the 
        achievement of the goals of the National HIV/AIDS Strategy, 
        including the goals of--
                    (A) reducing the number of people who become 
                infected with HIV;
                    (B) increasing access to care and optimizing health 
                outcomes for people living with HIV; and
                    (C) reducing HIV-related health disparities;
            (2) the extent to which the National HIV/AIDS Strategy has 
        improved coordination of efforts to maximize the effective 
        delivery of HIV/AIDS prevention, care, and treatment services 
        at the community level, including coordination--
                    (A) within and among Federal agencies and 
                departments;
                    (B) between the Federal Government and State and 
                local governments and health departments;
                    (C) between the Federal Government and nonprofit 
                foundations and civil society organizations, including 
                community- and faith-based organizations focused on 
                addressing the issue of HIV/AIDS; and
                    (D) between the Federal Government and private 
                businesses.
            (3) efforts by the Federal Government to educate, involve, 
        and establish and strengthen partnerships with civil society 
        organizations, including community- and faith-based 
        organizations, in order to implement the National HIV/AIDS 
        Strategy and achieve its goals;
            (4) how Federal resources are being deployed to implement 
        the Strategy, including--
                    (A) the amount of funding used to date, by each 
                Federal agency and department, to implement the 
                National HIV/AIDS Strategy;
                    (B) a brief summary for each Federal agency and 
                department of the number and function of all Federal 
                employees assisting in implementing the Strategy; and
                    (C) an estimate of the amount of funding necessary 
                to implement the National HIV/AIDS Strategy, by each 
                Federal agency and department, for the next fiscal 
                year; and
            (5) what additional steps, if any, are necessary to fully 
        implement the National HIV/AIDS Strategy, including--
                    (A) whether any existing statutory laws, policies, 
                or regulations are impeding the implementation of the 
                National HIV/AIDS Strategy, at the Federal, State, or 
                local level, and whether any changes to such laws, 
                policies, or regulations are necessary or recommended; 
                and
                    (B) whether any Federal agencies or departments 
                require additional statutory authority to effectively 
                carry out their duties as part of the National HIV/AIDS 
                Strategy.
    (c) Use of Previously Appropriated Funds.--Funding for the report 
required under subsection (a) shall derive from discretionary funds of 
the departments and agencies specified in such subsection.

SEC. 4. REPORT ON PROGRESS TOWARDS ACHIEVING UNIVERSAL ACCESS TO HIV/
              AIDS TREATMENT.

    (a) Report Required.--Not later than 6 months after the date of the 
enactment of this Act, the President, in consultation with the Global 
AIDS Coordinator and the heads of all relevant agencies, including the 
Department of State, the Department of Health and Human Services, the 
United States Agency for International Development, the Centers for 
Disease Control and Prevention, and the National Institutes of Health, 
shall transmit to the Congress and make publicly available a report on 
the status of international progress towards achieving universal access 
to HIV/AIDS treatment for people living with HIV/AIDS.
    (b) Contents.--The report required by subsection (a) shall include 
a description, analysis, and evaluation of--
            (1) the extent to which progress has been made in achieving 
        the goal of universal access to HIV/AIDS treatment on a 
        country, regional, and global basis, as well as addressing the 
        ongoing challenges and obstacles to achieving such goal, 
        including--
                    (A) for the prevention of mother-to-child 
                transmission;
                    (B) with respect to the most-at-risk populations 
                (MARPs) such as injection drug users, sex workers and 
                their clients, men who have sex with men, transgender 
                people, and prisoners;
                    (C) to ensure the availability of treatment as 
                prevention strategies;
                    (D) an estimate of the amount of funding and 
                resources provided to date in order to achieve the 
                goal, including funding and resources provided by--
                            (i) the United States;
                            (ii) partner countries;
                            (iii) the Global Fund to Fight AIDS, 
                        Tuberculosis and Malaria, UNAIDS, the World 
                        Health Organization, and other multilateral 
                        institutions;
                            (iv) other donor nations;
                            (v) nonprofit foundations and civil-society 
                        and nongovernmental organizations, including 
                        community- and faith-based organizations; and
                            (vi) private businesses; and
                    (E) an estimate of the amount of funding and 
                resources still needed to accomplish the goal;
            (2) how the United States is contributing to the 
        achievement of the goal of universal access to HIV/AIDS 
        treatment, including through--
                    (A) improved coordination and collaboration among 
                relevant Federal agencies and departments and among--
                            (i) the United States;
                            (ii) partner countries;
                            (iii) the Global Fund to Fight AIDS, 
                        Tuberculosis and Malaria, UNAIDS, the World 
                        Health Organization, and other multilateral 
                        institutions;
                            (iv) other donor nations;
                            (v) nonprofit foundations and civil-society 
                        and nongovernmental organizations, including 
                        community- and faith-based organizations; and
                            (vi) private businesses;
                    (B) the identification and utilization of 
                efficiencies in the delivery of HIV/AIDS treatment 
                services within and between United States funded 
                bilateral and multilateral programs, and partner 
                countries, including to the extent that such gains in 
                efficiencies are being exhausted;
                    (C) bilateral HIV/AIDS programs and other bilateral 
                global health programs;
                    (D) the Global Fund to Fight AIDS, Tuberculosis and 
                Malaria;
                    (E) ongoing research into new, simpler, more 
                effective, and cheaper HIV treatment regimens, 
                including operational research to ensure that such 
                treatments are adhered to and delivered quickly and 
                efficiently;
                    (F) bilateral and multilateral efforts to 
                strengthen recruitment, training, and retention of 
                skilled indigenous health workers within national 
                health systems of partner countries, including to 
                increase the effectiveness of such health workers and 
                ensure their equitable distribution within the country;
                    (G) bilateral and multilateral trade and investment 
                negotiations, policies, or agreements, especially in 
                cases affecting the price, quality, accessibility, and 
                affordability of pharmaceuticals, including second-line 
                pharmaceuticals, diagnostics, and medical products and 
                devices (including any patents for or generic 
                alternatives to such items) used to treat HIV/AIDS and 
                its associated opportunistic infections or diseases;
                    (H) participation, contribution, and leadership 
                within multilateral institutions including UNAIDS, the 
                World Health Organization, the United Nations, 
                international financial institutions, and other such 
                multilateral institutions; and
                    (I) the amount of funding and resources provided by 
                the United States to date, and an estimate of the 
                amount of funding and resources necessary for the next 
                fiscal year; and
            (3) the concept of ``Treatment 2.0'' as proposed by UNAIDS 
        and the World Health Organization to improve and expand HIV 
        treatment by optimizing drug regimens, simplifying laboratory 
        platforms for diagnosis and monitoring, reducing costs, 
        adapting delivery systems, and mobilizing communities, 
        including--
                    (A) the progress achieved to date and any 
                challenges and obstacles to the realization of the 
                proposal; and
                    (B) a summary of efforts by the United States in 
                contributing to the realization of the proposal, and 
                any such planned actions by the United States for the 
                next fiscal year, including--
                            (i) any proposed changes to United States 
                        statutory laws, policies, or regulations; and
                            (ii) the amount of funding and resources 
                        provided to date by the United States to 
                        support the proposal, and for the next fiscal 
                        year.
    (c) Use of Previously Appropriated Funds.--Funding for the report 
required under subsection (a) shall derive from existing discretionary 
funds of the departments and agencies specified in such subsection.

SEC. 5. DEFINITIONS.

    In this Act:
            (1) HIV and hiv/aids.--The terms ``HIV'' and ``HIV/AIDS'' 
        have the meanings given to such terms in section 2689 of the 
        Public Health Service Act (42 U.S.C. 300ff-88).
            (2) International financial institution.--The term 
        ``international financial institution'' means any of the 
        following institutions:
                    (A) The International Bank for Reconstruction and 
                Development.
                    (B) The International Development Association.
                    (C) The International Finance Corporation.
                    (D) The Multilateral Investment Guarantee Agency.
                    (E) The International Centre for Settlement of 
                Investment Disputes.
                    (F) The Inter-American Development Bank.
                    (G) The Asian Development Bank.
                    (H) The Asian Development Fund.
                    (I) The African Development Bank.
                    (J) The African Development Fund.
                    (K) The International Monetary Fund.
                    (L) The North American Development Bank.
                    (M) The European Bank for Reconstruction and 
                Development.
            (3) National hiv/aids strategy.--The term ``National HIV/
        AIDS Strategy'' means the National HIV/AIDS Strategy of the 
        United States developed by the President.
            (4) Treatment as prevention.--The term ``treatment as 
        prevention'' means the strategy of providing antiretroviral 
        treatment to people living with or vulnerable to HIV/AIDS in 
        order to decrease their risk of transmitting or becoming 
        infected with the virus. Such strategies may include--
                    (A) ``pre-exposure prophylaxis'' which means the 
                provision of antiretroviral drugs to uninfected 
                individuals before possible exposure to the virus; and
                    (B) ``test and treat'' which means the testing of 
                everyone for HIV/AIDS within a high-risk group or a 
                defined geographic area and the immediate provision of 
                antiretroviral treatment to everyone who tests positive 
                for the disease.
            (5) UNAIDS.--The term ``UNAIDS'' means the Joint United 
        Nations Programme on HIV/AIDS.
                                 <all>